Drugs will be tested simultaneously, which it's hoped will speed up the process of finding new treatments for this common ...

Nearly two-thirds of children that were found to have early-stage type 1 diabetes through a screening program in eight European countries had no parent or sibling with the disease ...

After five years of believing she had MS, Christina Applegate learned she’d been misdiagnosed. She’s far from the only star to receive an incorrect diagnosis.

A natural compound the body produces after consuming foods such as pomegranates may improve heart function by as much as 80% ...

Rising diabetes prevalence, about 724,000 diagnosed US cases in 2025, and late-stage candidates naronapride and deudomperidone (CIN-102) drive growth across the US, EU4, UK and Japan.Dublin, Oct. 21, ...

Safe completion of the first dose cohort in which QEL-005 was well tolerated, with no dose-limiting toxicities (DLTs), no treatment-related ...

Tuesday to advance $1 million for a new diabetes care program amid questions about the funding source and its sustainability.

Several factors have led to a pediatric endocrinologist shortage in the U.S. that has caused large care gaps for children, ...

Recce Pharmaceuticals Ltd (ASX:RCE, OTC:RECEF) has reached a key milestone in its pivotal Phase 3 diabetic foot infection trial, with an independent Data Monitoring Committee (DMC) set to review ...

Nobel-winning scientific breakthroughs have repeatedly emerged from organisms once considered too simple or too distant from human biology to be useful. Research on yeast revealed fundamental ...

GSK plc (LSE/NYSE: GSK) today announced the US Food and Drug Administration (FDA) has approved Jemperli (dostarlimab-gxly) as the first and only immunotherapy for adults with stage II and III ...

Weight loss also increased with the dose. Participants receiving 4 mg, 9 mg, or 12 mg of retatrutide lost an average of 11.5% ...